Clinical Trial Update: Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PRO-240 ophthalmic solution compared with Optive for dry eye disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Ocular Surface Disease

Drugs mentioned

• Optive
• PRO-240 ophthalmic solution (PRO-240)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Disease, Dry Eye Sensation | Phase 1 | Status: NOT_YET_RECRUITING